Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PRGO — PERRIGO Co plc

CIK 1423053 MIAMI, FL
Back to PRGO Full portfolio

Position in PRGO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$21,994,929
+$3,093,185 QoQ
Shares Held
2,047,945
+50.8% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in PRGO Over Time

Shares Held

Position Value (USD)

Derivatives in PRGO

reported options exposure · as of Mar 31, 2026
CallValue
$571,368
CallShares
53,200
PutValue
$483,300
PutShares
45,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $927,090,430 across 59 Drug Manufacturers - Specialty & Generic names. PRGO ranks #9 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 360,643 $213,854,086
2 INDV
Indivior Pharmaceuticals, Inc.
 3,574,044 $108,936,860
3 ELAN
Elanco Animal Health Inc
 4,387,127 $104,983,948
4 ALKS
Alkermes plc.
 2,241,584 $79,262,409
5 SUPN
Supernus Pharmaceuticals, Inc.
 1,493,446 $77,196,223
6 ZTS
Zoetis Inc.
 501,011 $59,224,510
7 VTRS
Viatris Inc
 3,993,155 $53,947,523
8 KNSA
Kiniksa Pharmaceuticals International, plc
 474,750 $22,859,212

All Filings in PRGO

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $21,994,929 2,047,945
2026-03-31 $483,300 45,000
2026-03-31 $571,368 53,200
2025-12-31 $4,756,464 341,700
2025-12-31 $1,262,544 90,700
2025-12-31 $18,901,744 1,357,884
2025-09-30 $1,556,673 69,900
2025-09-30 $908,616 40,800
2025-09-30 $4,065,165 182,540
2025-06-30 $750,832 28,100
2025-06-30 $10,825,420 405,143
2025-06-30 $1,779,552 66,600
2025-03-31 $2,890,924 103,100
2025-03-31 $51,728,331 1,844,805
2025-03-31 $922,516 32,900
2024-12-31 $1,550,313 60,300
2024-12-31 $2,907,801 113,100
2024-12-31 $48,961,712 1,904,384
2024-09-30 $1,458,388 55,600
2024-09-30 $82,776,082 3,155,779
2024-09-30 $1,906,921 72,700
2024-06-30 $1,414,968 55,100
2024-06-30 $56,964,197 2,218,232
2024-06-30 $3,980,400 155,000
2024-03-31 $2,237,205 69,500
2024-03-31 $88,894,197 2,761,547
2024-03-31 $3,795,201 117,900
2023-12-31 $1,879,312 58,400
2023-12-31 $1,866,440 58,000
2023-12-31 $41,661,000 1,294,624
2023-09-30 $501,615 15,700
2023-09-30 $18,123,157 567,235
2023-09-30 $808,335 25,300
2023-06-30 $573,755 16,900
2023-06-30 $370,055 10,900
2023-06-30 $47,235,618 1,391,329
2023-03-31 $92,733,777 2,585,274
2023-03-31 $394,570 11,000
2023-03-31 $807,075 22,500
2022-12-31 $797,706 23,400
2022-12-31 $41,220,161 1,209,157
2022-12-31 $995,428 29,200
2022-09-30 $994,914 27,900
2022-09-30 $948,556 26,600
2022-09-30 $73,273,454 2,054,780
2022-06-30 $1,123,789 27,700
2022-06-30 $94,516,740 2,329,720
2022-06-30 $2,231,350 55,000
2022-03-31 $1,402,695 36,500
2022-03-31 $2,271,213 59,100

Report a Problem

Category
Description
Email (optional, for follow-up)